Anterior Cruciate Ligament (ACL) Reconstruction
Conditions
Brief summary
The investigators hypothesize that perioperative oral administration of pregabalin would reduce postoperative pain and produce reduction in postoperative opioid consumption after anterior cruciate ligament (ACL) reconstruction . Patients are randomly assign to 1 of 2 groups. The placebo group receive placebo capsules 1 hour before surgery and 12 hours after initial dose. The pregabalin group receive pregabalin 150 mg, respectively at the same points.
Interventions
The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose.
The placebo group receive placebo 150 mg 1 hour before surgery and 12 hours after initial dose.
Sponsors
Study design
Intervention model description
Candidate for arthroscopic ACL reconstruction are divided into two groups of pregabalin and placebo with 48 patients in each group. The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose and a placebo is administered in control group.
Eligibility
Inclusion criteria
* age between 20-65 years * physical condition type I or II in ASA (American Society of Anesthesiology)
Exclusion criteria
* patients of ASA classification 3 or more * with a history of cardiovascular or respiratory disease * dizziness or frequent headache * active alcohol or drug usage, * intake of any analgesics daily or 48 hours before surgery * impaired renal and/or hepatic function
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain scores | 12 hours after surgery | Visual analog scale (VAS) score = 0-100 mm |
Secondary
| Measure | Time frame |
|---|---|
| Opioid consumption | the first 48 hours after surgery |
Countries
South Korea